Catherine Richards, PhD, MPH

Catherine Richards is the President & COO at OM1, inc. In her role as president Catherine is responsible for leading OM1’s four business units: Data & Insights, ASPEN, Research Services and PhenOM, as well as leads technology and compliance, all with the goal of ensuring a thriving company culture that delivers significant value to customers.

Prior to OM1 Catherine was the Chief Data Officer & General Manager of the Real World Evidence business unit at ConcertAI, where she was responsible for a 600+ person global team that created and delivered data products, custom data solutions and outcomes science services to the pharmaceutical industry.

Before ConcertAI, she was the Senior Vice President of Analytics & Scientific Engagement at Panalgo, where she led data integration, data operations and scientific engagement, including training and supporting users of Instant Health Data (IHD).

Previous to Panalgo she was the Director of User and Scientific Engagement for Aetion, supporting the use and adoption of the Aetion Evidence Platform and working as the scientific lead for five of the top 20 pharmaceutical companies.

Proceeding Aetion she was a staff scientist at the Hutchinson Institute for Cancer Outcomes Research (HICOR) at Fred Hutch in Seattle, Washington. While there the main focus of her research and academic activities was on improving the quality of cancer care while reducing the economic burden for patients and society.

Catherine received her MPH and PhD in Cancer Epidemiology from the Mailman School of Public Health At Columbia University.